Analyst Consensus ?
ConsensusHold39 ratings
Bullish1743.6%
Neutral1641.0%
Bearish615.4%
FN2 Earnings Intelligence
Molina Healthcare, Inc. complete analyst coverage
Molina Healthcare, Inc. (MOH) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$198.95Current
$124Low
$212.88Average
$400High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Neutral | Neutral | Maintain | Oct 27, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 23, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Oct 23, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 23, 2026 |
| Barclays | Underweight | Underweight | Maintain | Oct 23, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 28, 2026 |
| Truist Securities | Hold | Hold | Maintain | Jul 24, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jul 14, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | May 11, 2026 |
| Baird | Neutral | Neutral | Maintain | May 11, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Mar 12, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Feb 12, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Sep 5, 2025 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Feb 6, 2025 |
| Deutsche Bank | Hold | Hold | Maintain | Jul 29, 2024 |
| Jefferies | Hold | Hold | Maintain | Jul 24, 2024 |
| B of A Securities | Underperform | Neutral | Downgrade | Apr 1, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 28, 2023 |
| Loop Capital | Hold | Hold | Maintain | Jun 17, 2022 |
| BMO Capital | Outperform | Outperform | Maintain | Feb 14, 2022 |
| SVB Leerink | Outperform | Outperform | Maintain | Oct 30, 2020 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Jun 16, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 4, 2020 |
| Piper Sandler | Overweight | Overweight | Maintain | May 4, 2020 |
| CFRA | Buy | Hold | Upgrade | May 4, 2020 |
| Bank of America | Underperform | Underperform | Maintain | Aug 1, 2018 |
| Mitsubishi UFJ | Neutral | Neutral | Maintain | Sep 21, 2017 |
| Stifel Nicolaus | Sell | Hold | Downgrade | May 31, 2017 |
| Stifel | Sell | Hold | Downgrade | May 31, 2017 |
| Wolfe Research | Perform | Market Perform | Maintain | May 8, 2017 |
| PiperJaffray | Overweight | Overweight | Maintain | Jan 4, 2017 |
| Leerink Swann | Outperform | Outperform | Maintain | May 2, 2016 |
| Susquehanna | Positive | Positive | Maintain | Sep 18, 2015 |
| Sterne Agee | Buy | Buy | Maintain | Jun 27, 2014 |
| Monness, Crespi, Hardt | Buy | Buy | Maintain | May 2, 2014 |
| Monness Crespi Hardt | Buy | Buy | Maintain | May 2, 2014 |
| Wedbush | Outperform | Outperform | Maintain | Mar 14, 2013 |
| Citigroup | Buy | Buy | Maintain | Apr 9, 2012 |
| Bank oferica | Underperform | Underperform | Maintain | Feb 24, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $198.95. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Deutsche Bank | Analyst unavailable | $163 | $209.36 | -18.1% | Oct 26, 2026 |
| RBC Capital | Analyst unavailable | $222 | $208.11 | +11.6% | Oct 23, 2026 |
| Robert W. Baird | Analyst unavailable | $198 | $216.64 | -0.5% | Oct 23, 2026 |
| UBS | Analyst unavailable | $225 | $216.64 | +13.1% | Oct 23, 2026 |
| Barclays | Analyst unavailable | $178 | $216.64 | -10.5% | Oct 23, 2026 |
| Mizuho Securities | Jason Twizell | $255 | $216.64 | +28.2% | Oct 23, 2026 |
| Jefferies | David Windley | $220 | $216.64 | +10.6% | Oct 23, 2026 |
| Wells Fargo | Analyst unavailable | $220 | $199.48 | +10.6% | Jul 28, 2026 |
| RBC Capital | Ben Hendrix | $218 | $195.8 | +9.6% | Jul 24, 2026 |
| Barclays | Analyst unavailable | $180 | $200.29 | -9.5% | Jul 24, 2026 |
| Truist Financial | Analyst unavailable | $250 | $242.88 | +25.7% | Jul 14, 2026 |
| Jefferies | Analyst unavailable | $230 | $242.88 | +15.6% | Jul 14, 2026 |
| Wells Fargo | Analyst unavailable | $235 | $233.31 | +18.1% | Jul 13, 2026 |
| Bernstein | Analyst unavailable | $286 | $233.31 | +43.8% | Jul 13, 2026 |
| RBC Capital | Ben Hendrix | $248 | $233.43 | +24.7% | Jul 9, 2026 |
| Barclays | Andrew Mok | $184 | $232.9 | -7.5% | Jul 8, 2026 |
| RBC Capital | Analyst unavailable | $216 | $197.42 | +8.6% | Jun 23, 2026 |
| Mizuho Securities | Analyst unavailable | $215 | $190.86 | +8.1% | Jun 8, 2026 |
| Morgan Stanley | Analyst unavailable | $167 | $184.82 | -16.1% | Jun 4, 2026 |
| Barclays | Andrew Mok | $199 | $175.59 | +0.0% | May 26, 2026 |
| UBS | Analyst unavailable | $202 | $181.26 | +1.5% | May 22, 2026 |
| Truist Financial | Analyst unavailable | $205 | $186.49 | +3.0% | May 11, 2026 |
| Robert W. Baird | Michael Ha | $163 | $185.94 | -18.1% | May 11, 2026 |
| Truist Financial | Analyst unavailable | $180 | $176.89 | -9.5% | Apr 27, 2026 |
| Wells Fargo | Stephen Baxter | $159 | $175.94 | -20.1% | Apr 27, 2026 |
| Deutsche Bank | George Hill | $129 | $168.3 | -35.2% | Apr 24, 2026 |
| UBS | Analyst unavailable | $180 | $168.09 | -9.5% | Apr 24, 2026 |
| Morgan Stanley | Analyst unavailable | $146 | $169.9 | -26.6% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $161 | $174.51 | -19.1% | Apr 24, 2026 |
| UBS | Analyst unavailable | $173 | $148.78 | -13.0% | Mar 13, 2026 |
| Wells Fargo | Stephen Baxter | $141 | $148.24 | -29.1% | Feb 20, 2026 |
| Truist Financial | Analyst unavailable | $145 | $134.1 | -27.1% | Feb 17, 2026 |
| Goldman Sachs | Analyst unavailable | $124 | $122.65 | -37.7% | Feb 11, 2026 |
| Deutsche Bank | Analyst unavailable | $109 | $128.47 | -45.2% | Feb 10, 2026 |
| Barclays | Andrew Mok | $133 | $127.53 | -33.1% | Feb 10, 2026 |
| UBS | Analyst unavailable | $145 | $126.71 | -27.1% | Feb 9, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $144 | $128.79 | -27.6% | Feb 9, 2026 |
| Mizuho Securities | Ann Hynes | $220 | $183.5 | +10.6% | Jan 9, 2026 |
| Wells Fargo | Stephen Baxter | $208 | $184.73 | +4.5% | Jan 7, 2026 |
| Bernstein | Analyst unavailable | $224 | $184.04 | +12.6% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $164 | $178.46 | -17.6% | Jan 5, 2026 |
| Jefferies | Analyst unavailable | $160 | $163.42 | -19.6% | Dec 16, 2025 |
| Truist Financial | Analyst unavailable | $175 | $164.13 | -12.0% | Oct 24, 2025 |
| Morgan Stanley | Erin Wright | $158 | $161 | -20.6% | Oct 24, 2025 |
| UBS | Analyst unavailable | $170 | $161 | -14.6% | Oct 24, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $180 | $161 | -9.5% | Oct 24, 2025 |
| Goldman Sachs | Scott Fidel | $167 | $161 | -16.1% | Oct 24, 2025 |
| Deutsche Bank | Analyst unavailable | $165 | $163.73 | -17.1% | Oct 24, 2025 |
| Truist Financial | Analyst unavailable | $210 | $194.37 | +5.6% | Oct 14, 2025 |
| Morgan Stanley | Analyst unavailable | $204 | $193.76 | +2.5% | Oct 14, 2025 |
| Goldman Sachs | Scott Fidel | $207 | $194.27 | +4.0% | Oct 14, 2025 |
| Wells Fargo | Analyst unavailable | $231 | $200.57 | +16.1% | Oct 7, 2025 |
| Mizuho Securities | Ann Hynes | $330 | $221.55 | +65.9% | Jul 11, 2025 |
| Morgan Stanley | Erin Wright | $266 | $228.58 | +33.7% | Jul 10, 2025 |
| Morgan Stanley | Erin Wright | $364 | $297 | +83.0% | Jun 9, 2025 |
| Robert W. Baird | Michael Ha | $375 | $335.5 | +88.5% | Apr 15, 2025 |
| Wells Fargo | Analyst unavailable | $372 | $311.89 | +87.0% | Mar 5, 2025 |
| Mizuho Securities | Analyst unavailable | $376 | $302.84 | +89.0% | Mar 3, 2025 |
| Robert W. Baird | Michael Ha | $331 | $275 | +66.4% | Oct 24, 2024 |
| Wells Fargo | Stephen Baxter | $360 | $346.97 | +80.9% | Aug 5, 2024 |
| Jefferies | David Windley | $297 | $286.9 | +49.3% | Jul 24, 2024 |
| Truist Financial | David MacDonald | $400 | $292.84 | +101.1% | Jul 15, 2024 |
| Robert W. Baird | Michael Ha | $405 | $315 | +103.6% | May 29, 2024 |
| Barclays | Andrew Mok | $430 | $367.41 | +116.1% | Apr 25, 2024 |
| Wells Fargo | Stephen Baxter | $410 | $376.57 | +106.1% | Apr 15, 2024 |
| Wells Fargo | Stephen Baxter | $420 | $398.14 | +111.1% | Feb 15, 2024 |
| Barclays | Analyst unavailable | $375 | $318.92 | +88.5% | Jan 4, 2023 |
| Wells Fargo | Analyst unavailable | $340 | $318.92 | +70.9% | Jan 3, 2023 |
| Wells Fargo | Analyst unavailable | $345 | $327.5 | +73.4% | Aug 26, 2022 |
| Mizuho Securities | Analyst unavailable | $366 | $318.19 | +84.0% | Jul 29, 2022 |
| Barclays | Analyst unavailable | $380 | $319.47 | +91.0% | Jul 29, 2022 |
| Wells Fargo | Analyst unavailable | $301 | $312.59 | +51.3% | May 25, 2022 |
| Deutsche Bank | Analyst unavailable | $311 | $306.08 | +56.3% | May 2, 2022 |
| Stephens | Scott Fidel | $300 | $295.72 | +50.8% | Oct 29, 2021 |
| Barclays | Steven Valiquette | $340 | $295.72 | +70.9% | Oct 29, 2021 |
| Jefferies | David Windley | $253 | $244.16 | +27.2% | Apr 14, 2021 |
Track every rating change on MOH the moment it posts. Free to start.
Start freeGet the MOH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.